Thoracoscopic Lobectomy Facilitates the Delivery of Chemotherapy after Resection for Lung Cancer

Annals of Thoracic Surgery

Volumn 83, Issue 4, 2007, Pages 1245-1250

  Petersen, Rebecca P ^a   Pham, DuyKhanh ^a   Burfeind, William R ^a   Hanish, Steven I ^a   Toloza, Eric M ^a   Harpole Jr , David H ^a   D'Amico, Thomas A ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GEMCITABINE; PLATINUM DERIVATIVE; TAXANE DERIVATIVE; VINCA ALKALOID;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CONTROLLED STUDY; DRUG DOSE REGIMEN; FEMALE; HEART ATRIUM FIBRILLATION; HOSPITALIZATION; HUMAN; HUMAN TISSUE; LENGTH OF STAY; LOBECTOMY; LUNG NON SMALL CELL CANCER; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PNEUMONIA; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RESPIRATORY FAILURE; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; STUDENT T TEST; SURGICAL MORTALITY; THORACOSCOPY; THORACOTOMY; THORAX DRAINAGE; TOXICITY TESTING; TREATMENT PLANNING;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIOPSY, NEEDLE; CARCINOMA, NON-SMALL-CELL LUNG; CHEMOTHERAPY, ADJUVANT; COHORT STUDIES; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PATIENT COMPLIANCE; PNEUMONECTOMY; PROBABILITY; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS; THORACOSCOPY; THORACOTOMY; TREATMENT OUTCOME;

EID: 33947304369     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2006.12.029     Document Type: Article

References (27)

1. Daniels L.J., Balderson S.S., Onaitis M.W., and D'Amico T.A. Thoracoscopic lobectomy: a safe and effective strategy for patients with stage I lung cancer. Ann Thorac Surg 74 (2002) 860-864
2. Demmy T.L., and Curtis J.J. Minimally invasive lobectomy directed toward frail and high-risk patients: a case control study. Ann Thorac Surg 68 (1999) 194-200
3. McKenna R.J., Houck W., and Fuller C.B. Video-assisted thoracic surgery lobectomy: experience with 1100 cases. Ann Thorac Surg 81 (2006) 421-426
4. Nagahiro I., Andou A., Aoe M., et al. Pulmonary function, postoperative pain, and serum cytokine level after lobectomy: a comparison of VATS and conventional procedure. Ann Thorac Surg 72 (2001) 362-365
5. Nomori H., Horio H., Naruke T., and Suemasu K. What is the advantage of a thoracoscopic lobectomy over a limited anterior thoracotomy procedure for lung cancer surgery?. Ann Thorac Surg 72 (2001) 879-884
6. Onaitis M.W., Petersen P.R., Balderson S.S., et al. Thoracoscopic lobectomy is a safe and versatile procedure: experience with 500 consecutive patients. Ann Surg 244 (2006) 420-425
7. Petersen R.P., Pham D.K., Toloza E.M., et al. Thoracoscopic lobectomy: a safe and effective strategy for patients receiving induction therapy for non-small cell lung cancer. Ann Thorac Surg 82 (2006) 214-219
8. Roviaro G., Varoli F., Vergani C., and Maciocco M. Video-assisted thoracoscopic surgery (VATS) major pulmonary resections: the Italian experience. Semin Thorac Cardiovasc Surg 10 (1998) 313-320
9. Swanson S.J., Herndon J., D'Amico T.A., et al. Results of CALGB 39802: feasibility of VATS lobectomy for lung cancer. Proc Am Soc Clin Oncol 21 (2002) 290a
10. Walker W.S., Codispoti M., Soon S.Y., et al. Long-term outcomes following VATS lobectomy for non-small cell bronchogenic carcinoma. Eur J Cardiothorac Surg 23 (2003) 397-402
11. Yim A.P.C., Wan S., Lee T.W., et al. VATS lobectomy reduced cytokine responses compared with conventional surgery. Ann Thorac Surg 70 (2000) 243-247
12. Koizumi K., Haraguchi S., Hirata T., et al. Lobectomy by video-assisted thoracic surgery for lung cancer patients aged 80 years or more. Ann Thorac Cardiovasc Surg 9 (2003) 14-21
13. McKenna R.J., and Fischel R.J. VATS lobectomy and lymph node dissection or sampling in eighty-year-old patients. Chest 106 (1994) 1902
14. Arriagada R., Bergman B., Dunant A., et al. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. N Engl J Med 350 (2004) 351-360
15. Strauss G.M., Herndon J., Maddaus M.A., et al. Randomized clinical trial of adjuvant chemotherapy with paclitaxel and carboplatin following resection in stage IB non-small cell lung cancer (NSCLC) report of Cancer and Leukemia Group B (CALGB) protocol 9633. J Clin Oncol 22 suppl 14 (2004) A7019
16. Winton T.L., Livingston R., Johnson D., et al. Vinorelbine plus cisplatin vs observation in resected non-small cell lung cancer. N Engl J Med 352 (2005) 2589-2597
17. Douillard J.Y., Rosell R., Delena M., Legroumellec A., Torres A., Carpagano F., and Adjuvant Navelbine International Trialist Association (ANITA). Phase III adjuvant vinorelbine and cisplatin versus observation in completely resected non-small-cell lung cancer patients: final results after 70-month median follow-up. [abstract]. J Clin Oncol 23 (2005) A7013
18. Burfeind W.R., and D'Amico T.A. Thoracoscopic lobectomy. Operative Techniques in Thoracic and Cardiovascular Surgery 9 (2004) 98-114
19. Demmy T.L., James T.A., Swanson S.J., McKenna R.J., and D'Amico T.A. Troubleshooting VATS lobectomy. Ann Thorac Surg 79 (2005) 1744-1753
20. Suguira H., Morikawa T., Kaji M., et al. Long-tern benefits for the quality of life after video-assisted toracoscopic lobectomy in patients with lung cancer. Surg Laparosc Endosc 9 (1999) 403-410
21. Nakata M., Sakei H., Yokoyama N., et al. Pulmonary function after lobectomy: video-assisted thoracic surgery versus thoracotomy. Ann Thorac Surg 70 (2000) 938-941
22. Nomori H., Ohtsuka T., Horio H., et al. Difference in the impairment of vital capacity and 6-minute walking after a lobectomy after a lobectomy performed by thoracoscopic surgery, an anterior limited thoracotomy, an antero-axillary thoracotomy, and a posterolateral thoracotomy. Surg Today 33 (2003) 7-12
23. Ettinger D.S., Bepler G., Bueno R., et al., National Comprehensive Cancer Network (NCCN). Non-small cell lung cancer clinical practice guidelines in oncology. J Natl Compr Canc Netw 2 (2004) 94-124
24. Rapp E., Pater J., Willan A., et al. Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer-report of a Canadian multicenter randomized trial. J Clin Oncol 6 (1988) 633-641
25. Bonadonna G., Valagussa P., Moliterni A., et al. Adjuvant cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer: the results of 20 years of follow-up. N Engl J Med 332 (1995) 901-926
26. Lally B.E., Zelterman D., Colasanto J.M., et al. Postoperative radiotherapy for stage II or III non-small-cell lung cancer using the Surveillance, Epidemiology, and End Results database. J Clin Oncol 24 (2006) 2998-3006
27. Lohrisch C., Paltiel C., Gelmon K., Speers C., et al. Impact on survival of time from definitive surgery to initiation of adjuvant chemotherapy for early-stage breast cancer. J Clin Oncol 24 (2006) 4888-4894